Charles River Laboratories International, Inc. (CRL)
345.37
+5.71
(+1.68%)
USD |
NYSE |
Oct 23, 16:00
345.15
-0.22
(-0.06%)
After-Hours: 20:00
Charles River Laboratories International Price to Book Value : 5.805 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.805 |
| October 22, 2026 | 5.709 |
| October 21, 2026 | 5.796 |
| October 20, 2026 | 5.302 |
| October 19, 2026 | 5.043 |
| October 16, 2026 | 5.045 |
| October 15, 2026 | 5.147 |
| October 14, 2026 | 5.076 |
| October 13, 2026 | 5.026 |
| October 12, 2026 | 5.074 |
| October 09, 2026 | 5.072 |
| October 08, 2026 | 5.009 |
| October 07, 2026 | 5.047 |
| October 06, 2026 | 5.126 |
| October 05, 2026 | 5.223 |
| October 02, 2026 | 4.878 |
| October 01, 2026 | 4.821 |
| September 30, 2026 | 4.958 |
| September 29, 2026 | 4.974 |
| September 28, 2026 | 4.951 |
| September 25, 2026 | 4.922 |
| September 24, 2026 | 4.949 |
| September 23, 2026 | 4.661 |
| September 22, 2026 | 4.792 |
| September 21, 2026 | 4.690 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.674 |
| September 17, 2026 | 4.734 |
| September 16, 2026 | 4.595 |
| September 15, 2026 | 4.586 |
| September 14, 2026 | 4.590 |
| September 11, 2026 | 4.677 |
| September 10, 2026 | 4.588 |
| September 09, 2026 | 4.678 |
| September 08, 2026 | 4.719 |
| September 04, 2026 | 4.849 |
| September 03, 2026 | 4.931 |
| September 02, 2026 | 4.904 |
| September 01, 2026 | 4.746 |
| August 31, 2026 | 4.845 |
| August 28, 2026 | 4.900 |
| August 27, 2026 | 4.982 |
| August 26, 2026 | 4.96 |
| August 25, 2026 | 5.003 |
| August 24, 2026 | 5.018 |
| August 21, 2026 | 4.962 |
| August 20, 2026 | 4.899 |
| August 19, 2026 | 4.874 |
| August 18, 2026 | 4.693 |
| August 17, 2026 | 4.818 |
| August 14, 2026 | 4.707 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Fortrea Holdings, Inc. | 4.287 |
| IQVIA Holdings, Inc. | 7.451 |
| Medpace Holdings, Inc. | 31.92 |
| Champions Oncology, Inc. | 16.88 |
| Avantor, Inc. | 2.078 |
Price to Book Value Related Metrics
| PS Ratio | 4.224 |
| PEG Ratio | -0.2673 |
| Price to Free Cash Flow | 45.57 |
| Price | 345.37 |
| Earnings Yield | -1.40% |
| Market Cap | 16.48B |
| PEGY Ratio | -0.2673 |
| Operating PE Ratio | 31.25 |
| Normalized PE Ratio | 183.56 |